OCA
Octagon Capital Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-450,000
| Closed | -$6.07M | – | 35 |
|
|
2025
Q1 | $6.07M | Sell |
450,000
-420,000
| -48% | -$5.66M | 1.17% | 27 |
|
|
2024
Q4 | $16.7M | Hold |
870,000
| – | – | 2.74% | 13 |
|
|
2024
Q3 | $19.8M | Buy |
870,000
+250,000
| +40% | +$5.69M | 3.08% | 11 |
|
|
2024
Q2 | $8.07M | Hold |
620,000
| – | – | 1.27% | 19 |
|
|
2024
Q1 | $10.9M | Hold |
620,000
| – | – | 1.3% | 22 |
|
|
2023
Q4 | $13.5M | Sell |
620,000
-447,143
| -42% | -$9.74M | 2.16% | 13 |
|
|
2023
Q3 | $16.4M | Buy |
1,067,143
+144,143
| +16% | +$2.21M | 2.52% | 12 |
|
|
2023
Q2 | $22M | Sell |
923,000
-262,000
| -22% | -$6.23M | 3.06% | 8 |
|
|
2023
Q1 | $30.1M | Buy |
1,185,000
+360,800
| +44% | +$9.18M | 4.34% | 6 |
|
|
2022
Q4 | $24.1M | Buy |
+824,200
| New | +$24.1M | 3.75% | 8 |
|